HDFC Pharma and Healthcare Fund - Growth Option

  • Scheme Category:  
  • Equity Scheme >  
  • Sectoral/Thematic Funds
NAV: ₹ 19.539 ↑ 0.18%
[as on 11 June, 2026]

NAV chart

SMA (Simple Moving Average)

  • 50 SMA
  • 100 SMA
  • 200 SMA
  • 400 SMA

Returns

CAGR returns till date

CAGR returns of HDFC Pharma and Healthcare Fund - Growth Option and its peers as on 11 June, 2026
NameYTD1D1W1M3M1Y3Y5Y7Y10Y
HDFC Pharma and Healthcare Fund - Growth Option 13.73% 0.18% 0.84% 1.63% 10.88% 17.27%----
SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN -GROWTH 11.19% -0.35% 1.96% 2.33% 9.07% 9.9% 24.85% 15.44% 22.97% 13.29%
SBI ESG Exclusionary Strategy Fund - Regular Plan - Growth -8.13% -0.55% -0.69% -1.73% -0.2% -5.65% 9.57% 9.22% 11.07% 11.5%
SBI INFRASTRUCTURE FUND - REGULAR PLAN - GROWTH -1.68% -1.06% -3.1% -3.79% 5.24% -2.86% 16.75% 17.48% 17.29% 15.06%
SBI PSU Fund - REGULAR PLAN -Growth 0.22% -0.7% -1.87% -2.86% -3.02% 4.36% 28.14% 22.04% 18.1% 14.77%
SBI CONSUMPTION OPPORTUNITIES FUND - REGULAR - GROWTH -10.45% -0.77% -1% -4.57% -1.03% -11.06% 7.07% 11.95% 13.4% 13.37%

Discrete returns (yearly)

Year2016201720182019202020212022202320242025
Returns-------- 50.48% 0.54%

Discrete returns (monthly)

MonthAug 2025Sep 2025Oct 2025Nov 2025Dec 2025Jan 2026Feb 2026Mar 2026Apr 2026May 2026
Returns -1.55% -1.54% 2.06% 1.12% -1.48% -4.75% 6.9% -4.45% 7.74% 5%

Returns from spefic dates

DescriptionCAGR returns from 26 Sep 2024 (Nifty 50 2024 high)
Returns 12.3%

Portfolio

Asset allocation

EquityDebtRealestateCommoditiesCash & Equivalents
98.52% 0.00% (Arbitrage: 0.00%) 0.00% 0.00% 1.48%

Equity

NameSymbol / ISINSectorWeight %
Sun Pharmaceutical Industries Ltd.SUNPHARMA (INE044A01036)Pharmaceuticals & Biotechnology10.20%
Divis Laboratories Ltd.DIVISLAB (INE361B01024)Pharmaceuticals & Biotechnology8.20%
Glenmark Pharmaceuticals Ltd.GLENMARK (INE935A01035)Pharmaceuticals & Biotechnology6.78%
Lupin Ltd.LUPIN (INE326A01037)Pharmaceuticals & Biotechnology6.65%
Alkem Laboratories Ltd.ALKEM (INE540L01014)Pharmaceuticals & Biotechnology5.99%
Max Healthcare Institute LimitedMAXHEALTH (INE027H01010)Healthcare Services5.96%
Aster DM Healthcare LimitedASTERDM (INE914M01019)Healthcare Services5.70%
Ipca Laboratories Ltd.IPCALAB (INE571A01038)Pharmaceuticals & Biotechnology5.16%
Acutaas Chemicals LimitedACUTAAS (INE00FF01025)Pharmaceuticals & Biotechnology4.39%
Anthem Biosciences LimitedANTHEM (INE0CZ201020)Pharmaceuticals & Biotechnology4.29%
Fortis Healthcare LimitedFORTIS (INE061F01013)Healthcare Services3.49%
Krishna Institute Of Medical Sciences LimitedKIMS (INE967H01025)Healthcare Services3.10%
Laurus Labs Ltd.LAURUSLABS (INE947Q01028)Pharmaceuticals & Biotechnology2.76%
Metropolis Healthcare Ltd.METROPOLIS (INE112L01020)Healthcare Services2.37%
Torrent Pharmaceuticals Ltd.TORNTPHARM (INE685A01028)Pharmaceuticals & Biotechnology2.34%
Eris Lifesciences LtdERIS (INE406M01024)Pharmaceuticals & Biotechnology2.24%
Vijaya Diagnostic Centre LimitedVIJAYA (INE043W01024)Healthcare Services2.13%
Sai Life Sciences LimitedSAILIFE (INE570L01029)Pharmaceuticals & Biotechnology2.09%
Shilpa Medicare LtdSHILPAMED (INE790G01031)Pharmaceuticals & Biotechnology1.91%
Global Health LimitedMEDANTA (INE474Q01031)Healthcare Services1.88%
Dr. Lal Path Labs LtdLALPATHLAB (INE600L01024)Healthcare Services1.57%
Neuland Laboratories LimitedNEULANDLAB (INE794A01010)Pharmaceuticals & Biotechnology1.54%
Wockhardt Ltd.WOCKPHARMA (INE049B01025)Pharmaceuticals & Biotechnology1.54%
Jubilant Pharmova LimitedJUBLPHARMA (INE700A01033)Pharmaceuticals & Biotechnology1.31%
Thyrocare Technologies Ltd.THYROCARE (INE594H01019)Healthcare Services1.27%
Rubicon Research LimitedRUBICON (INE506V01022)Pharmaceuticals & Biotechnology1.24%
Gland Pharma Ltd.GLAND (INE068V01023)Pharmaceuticals & Biotechnology1.07%
BAJAJ HEALTHCARE LIMITEDBAJAJHCARE (INE411U01027)Pharmaceuticals & Biotechnology0.83%
Laxmi Dental LimitedLAXMIDENTL (INE0WO601020)Healthcare Equipment & Supplies0.52%
Portfolio data is as on date 31 March, 2026

NAV history

HDFC Pharma and Healthcare Fund - Growth Option - 30 days NAV (Net asset value) history

DateNAV% change
11 June, 202619.539 0.18%
10 June, 202619.504 -0.66%
9 June, 202619.634 0.59%
8 June, 202619.519 0.06%
5 June, 202619.507 0.67%
4 June, 202619.377 0.79%
3 June, 202619.226 0.35%
2 June, 202619.159 0.02%
1 June, 202619.155 -0.78%
29 May, 202619.305 -0.42%
27 May, 202619.386 -0.05%
26 May, 202619.395 0.43%
25 May, 202619.312 0.11%
22 May, 202619.29 -1.12%
21 May, 202619.509 0.21%
20 May, 202619.468 0.28%
19 May, 202619.413 0.72%
18 May, 202619.274 0.2%
15 May, 202619.235 -0.21%
14 May, 202619.275 1.6%
13 May, 202618.972 0.47%
12 May, 202618.884 -1.77%
11 May, 202619.225 0.59%
8 May, 202619.112 0.45%
7 May, 202619.027 0.31%
6 May, 202618.969 1.69%
5 May, 202618.654 0.23%
4 May, 202618.611 2.02%
30 April, 202618.242 -0.01%
29 April, 202618.243

FAQ (Frequently asked questions)

  • What is latest/current NAV/price of HDFC Pharma and Healthcare Fund - Growth Option?
    The latest NAV of HDFC Pharma and Healthcare Fund - Growth Option is 19.539 as on 11 June, 2026.
  • What are YTD (year to date) returns of HDFC Pharma and Healthcare Fund - Growth Option?
    The YTD (year to date) returns of HDFC Pharma and Healthcare Fund - Growth Option are 13.73% as on 11 June, 2026.
  • What are 1 year returns of HDFC Pharma and Healthcare Fund - Growth Option?
    The 1 year returns of HDFC Pharma and Healthcare Fund - Growth Option are 17.27% as on 11 June, 2026.